Immunotherapy offers hope for once nearly-untreatable cancers

Though scientists have explored immunotherapy for more than 100 years, only recently has it been taken seriously, said James Allison, chair of the department of immunology, co-director of the Parker Institute for Cancer Immunotherapy, and executive director of the Immunotherapy Platform at MD Anderson Cancer Center in Houston. Allison, who shared the 2018 Nobel Prize in Physiology or Medicine, has conducted pioneering research into T cells, the foot soldiers of the body’s immune response to foreign invaders.

Allison studied a certain protein that acts as a brake on T cells and prevents them from responding uncontrollably. But this brake can also undermine the body’s response to cancer. For various reasons, T cells were being shut down before they could kill tumors. Allison was able to create a breakthrough “checkpoint inhibitor” therapy to remove this brake, freeing the T cells to continue the battle as long as needed.

Follow the latest news and policy debates on agricultural biotech and biomedicine? Subscribe to our newsletter.

This pioneering approach has led to promising new treatments for numerous cancers, like advanced melanoma. Survival rates have been boosted from about seven months, on average, to at least five years for more than half of advanced melanoma patients… While immunotherapy will not fully replace other therapies, like chemotherapy and surgery, he predicted, it will complement them.

Read the original post

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: What are mRNA COVID-19 vaccines and how do they work?

Infographic: What are mRNA COVID-19 vaccines and how do they work?

As of 1 December 2020, thirteen vaccines have reached the final stage of testing: where they are being given to ...
favicon

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend